Oren Livnat Stock Analyst Profile - HC Wainwright & Co. Research Coverage - Stocknear

Oren Livnat

Stock Analyst at HC Wainwright & Co.

(4.7)
# 1200
Out of 5,506 analysts
210
Total ratings
Success rate
Average return

28 Stocks

Name Action PT Current % Upside Ratings Updated
PCRX Pacira BioSciences
Maintains: Strong Buy
48 65
24.84 161.67% 20 Apr 8, 2025
VRCA Verrica Pharmaceutic...
Reiterates: Neutral
n/a
n/a n/a 12 Apr 8, 2025
COLL Collegium Pharmaceut...
Reiterates: Buy
50 50
34.61 44.47% 10 Mar 24, 2025
TRVI Trevi Therapeutics
Reiterates: Buy
13 13
9.88 26.52% 7 Mar 19, 2025
ANIP ANI Pharmaceuticals
Reiterates: Buy
94 94
89.64 4.86% 13 Mar 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
20 20
9.75 105.13% 9 Mar 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
200 217
139.48 55.58% 17 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
7 8
8.2 -2.44% 11 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
21 21
15.01 39.91% 16 Mar 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
73 73
65.17 12.01% 9 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
12 12
3.02 297.35% 1 Feb 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
12 12
n/a n/a 2 Sep 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 13 Jun 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
8 8
5.76 30.21% 6 Jan 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
12
n/a n/a 9 Jun 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 6 Apr 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 7 Aug 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
11 10
n/a n/a 4 Aug 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
24 17
n/a n/a 6 Aug 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 4 Aug 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
14 8
0.8 900% 2 May 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
6
n/a n/a 4 Apr 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
4 5
n/a n/a 5 Jan 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
43 60
3.35 1676.12% 5 Aug 26, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
11 8
n/a n/a 2 Jul 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
252 198
n/a n/a 2 May 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
4 3
n/a n/a 6 Aug 7, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
13
n/a n/a 2 Oct 15, 2018